Kewaunee Scientific

KEQU · NASDAQ

$32.92+$0.82 (+2.55%)TodayMarket closed ·
No price history for this range.

Latest news

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • Press releasePRNewswire

    Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2027

  • Press releasePRNewswire

    Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2027

  • News

    Kewaunee Scientific Q4 EPS $1.13 Down From $1.63 YoY, Sales $71.400M Down From $77.148M YoY

  • Press releasePRNewswire

    Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter

  • News

    Earnings Scheduled For June 23, 2026

  • Press releasePRNewswire

    Kewaunee Scientific to Report Results for Fiscal Year and Fourth Quarter

  • Press releasePRNewswire

    Kewaunee Scientific Corporation Appoints Jorge Santos as Vice President of International Sales, Laboratory Products Group

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • Press releasePRNewswire

    Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2026

  • News

    Earnings Scheduled For March 11, 2026

  • Press releasePRNewswire

    Kewaunee Scientific and Nu Aire Inc. to Attend analytica 2026 in Munich

  • Press releasePRNewswire

    Kewaunee Scientific to Report Results for Third Quarter Fiscal Year 2026

  • News

    Kewaunee Scientific Q2 Adj. EPS $0.91 Down From $1.41 YoY, Sales $70.096M Up From $47.764M YoY

  • Press releasePRNewswire

    Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2026

  • Press releasePRNewswire

    Kewaunee Scientific Announces Successful Debt Refinancing and Full Repayment of Seller Notes From the Company's Acquisition of Nu Aire, Inc.

  • Press releasePRNewswire

    Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2026

  • Press releasePRNewswire

    Kewaunee Scientific Announces Appointment of J. Jette Campbell to Board of Directors

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • Press releasePRNewswire

    Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2026

  • Press releasePRNewswire

    Kewaunee Scientific to Attend the 2025 Arablab Live Trade Show in Dubai

  • Press releasePRNewswire

    Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2026

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • Press releasePRNewswire

    Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter

  • Press releasePRNewswire

    Kewaunee Scientific to Report Results for Fiscal Year and Fourth Quarter

  • Press releasePRNewswire

    Kewaunee Scientific Announces Amendment to Share Repurchase Program

  • Press releasePRNewswire

    Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2025

  • Press releasePRNewswire

    Kewaunee Scientific to Report Results for Third Quarter Fiscal Year 2025

  • Press releasePRNewswire

    Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2025

  • Press releasePRNewswire

    Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2025

  • Press releasePRNewswire

    Kewaunee Scientific Corporation Completes Acquisition of Nu Aire

  • Press releaseBusiness Wire

    Kaskela Law LLC Announces Shareholder Investigation of Kewaunee Scientific Corp. (NASDAQ: KEQU) and Encourages Investors to Contact the Firm

  • Press releasePRNewswire

    Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2025

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.